Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.
Clinical Benefit
| Insufficient |
The actual benefit of LERCAPRESS 10 mg/10 mg is insufficient in view of the available clinical data: this data is insufficient to assess its value for the management of hypertensive patients. |
| Substantial |
|
Clinical Added Value
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
zYq8jxYF99MPjUAz
Listen
